Authors/Disclosures
|
|
No disclosure on file |
|
Evdokia Eleftheriou, MD
(Maine Medical Partners Neurology)
|
No disclosure on file |
|
Calvin Chan, MbChB
(Palmerston North Hospital)
|
No disclosure on file |
|
Marcondes C. Franca, Jr., MD
|
Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA. |
|
Anas Hannoun, MD
(Dartmouth-Hitchcock Manchester)
|
No disclosure on file |
|
Simone Appenzeller, PhD
|
No disclosure on file |
|
Margaret A. Owegi, DO
(University of Massachusetts Medical Center)
|
No disclosure on file |
|
|
No disclosure on file |
|
Iscia Lopes-Cendes, MD, PhD
(University of Campinas - UNICAMP)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Carolina Ionete, MD
(UMass Memorial)
|
Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH. |
|
Jan Schepel
|
No disclosure on file |
|
Fernando Cendes, MD, PhD, FAAN
(Departamento de Neurologia; FCM; UNICAMP)
|
Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH. |
|
Peter N. Riskind, MD, PhD
(UMASS Memorial Hlth Ctr/Dept of Neuro)
|
No disclosure on file |